title: Hemoglobin C in transgenic mice: effect of HbC expression from founders to full mouse globin knockouts.
abstract: When present in the homozygous form, hemoglobin C (HbC, CC disease) increases red cell density, a feature that is the major factor underlying the pathology in patients with SC disease (Fabry et al., JCI 70, 1315, 1982). The basis for the increased red cell density has not yet been fully defined. We have generated a HbC mouse in which the most successful founder expresses 56% human alpha and 34% human beta(C). We introduced knockouts (KO) of mouse alpha- and beta-globins in various combinations. In contrast to many KO mice, all partial KOs have normal MCH. Full KOs that express exclusively HbC and no mouse globins have minimally reduced MCH (13. 7 +/- 0.3 pg/cell vs 14.5 +/- 1.0 for C57BL/6) and a ratio of beta- to alpha-globin chains of 0.88 determined by chain synthesis; hence, these mice are not thalassemic. Mice with beta(C) > 30% have increased MCHC, dense reticulocytes, and increased K:Cl cotransport. Red cell morphology studied by SEM is strikingly similar to that of human CC cells with bizarre folded cells. We conclude that red cells of these mice have many properties that closely parallel the pathology of human disease in which HbC is the major determinant of pathogenesis. These studies also establish the existence of the interactions with other gene products that are necessary for pleiotropic effects (red cell dehydration, elevated K:Cl cotransport, morphological changes) that are also present in these transgenic mice, validating their usefulness in the analysis of pathophysiological events induced by HbC in red cells.
authors.affiliation: Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, New York 10461, USA. fabry@aecom.yu.edu
authors.forename: M E
authors.initials: ME
authors.lastname: Fabry
authors.forename: J R
authors.initials: JR
authors.lastname: Romero
authors.forename: S M
authors.initials: SM
authors.lastname: Suzuka
authors.forename: J G
authors.initials: JG
authors.lastname: Gilman
authors.forename: A
authors.initials: A
authors.lastname: Feeling-Taylor
authors.forename: E
authors.initials: E
authors.lastname: Odunusi
authors.forename: S M
authors.initials: SM
authors.lastname: Factor
authors.forename: E E
authors.initials: EE
authors.lastname: Bouhassira
authors.forename: C
authors.initials: C
authors.lastname: Lawrence
authors.forename: R L
authors.initials: RL
authors.lastname: Nagel
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001692:Biological Transport; D001853:Bone Marrow / Q000473:pathology; D001947:Breeding; D002118:Calcium / Q000494:pharmacology; D002412:Cations / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D004909:Erythrocyte Indices; D004912:Erythrocytes / Q000166:cytology / Q000378:metabolism / Q000648:ultrastructure; D005260:Female; D018703:Founder Effect; D015870:Gene Expression; D005838:Genotype; D005914:Globins / Q000235:genetics / Q000378:metabolism; D006444:Hemoglobin C / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D008855:Microscopy, Electron, Scanning; D011188:Potassium / Q000378:metabolism; D012156:Reticulocytes / Q000166:cytology; D013156:Splenectomy
chemical_list: D002412:Cations; D005914:Globins; D006444:Hemoglobin C; D000410:Alanine Transaminase; D011188:Potassium; D002118:Calcium